Pre- and post-exposure rabies prophylaxis: Who to vaccinate and how?;Prophylaxie pré- et postexpositionnelle de la rage: Qui vacciner et comment?

Revue Medicale Suisse

Volumn 1, Issue 19, 2005, Pages 1280-1283

  Senn, Nicolas ^a   Genton, Blaise ^a,b  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BAT; DOG; FATALITY; HUMAN; PUBLIC HEALTH; RABIES; REVIEW; SWITZERLAND; VACCINATION; ANIMAL; DISEASE TRANSMISSION; IMMUNOLOGY; RABIES VIRUS;

RABIES VACCINE;

ANIMALS; HUMANS; RABIES; RABIES VACCINES; RABIES VIRUS;

EID: 22844432346     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. OFSP Supplément X. Classeur «Maladies infectieuses- diagnostic et prévention». Prophylaxie pré- et post-expositionnelle de la rage chez l'homme, juillet 2004.
2. World Health Organisation. Rabies vaccines. WHO position paper. Epidemiologic Record 2002;77:109-19.
3. Gode GR, Bhide NK. Two rabies deaths after corneal grafts from one donor. Lancet 1988;2:791.
4. http://www.eurosurveillance.org/ew/2005/050217,asp
5. Rupprecht CE, Gibbons RV. Clinical practice. Prophylaxis against rabies. N Engl J Med 2004;3S1: 2626-35.
6. Hatz Ch FR, Loutan L. La rage chez le voyageur: prévenir et traiter. Med Hyg 2002;60:959-61.
7. Schlüter H Rabies-freearea-epidemiological definitions. Rabies Bulletin Europe 1999;23:10-1.
8. Perler L La Suisse de nouveau indemne de rage. Magazine de I'OVF, 3/2004:15.
9. Strady C, Jaussaud R, Beguinot I, Lienard M, Strady A Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: Validation of a new booster dose strategy. Vaccine 2000; 18:2661-7.
10. Strady A, Lang J, Lienard M, Blondeau C, Jaussaud R, Plotkin SA. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 1998;177:1290-5.
11. Human rabies prevention-United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-1):1-21.
12. Thisyakorn U, Pancharoen C, Wilde H. Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination. Vaccine 2001;19:1534-7.
13. Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin Infect Dis. 2001;33:E122-4.
14. Jaijaroensup W, Tantawichien T, Khawplod P, Tepsumethanon S, Wilde H. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin Infect Dis 1999;28:913-4.
15. Sriaroon C, Daviratanasilpa S, Sansomranjai P, et al. Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immune globulin. Vaccine. 2003;21:3525-6.